Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Operational and financial implications of GLP-1 agonist reimbursement among independent community pharmacies.

Journal of the American Pharmacists Association : JAPhA·2026

Same author

UPCODING MEDICARE: IS HEALTHCARE FRAUD AND ABUSE INCREASING?

Perspectives in health information management·2022

Same author

COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome.

The Journal of ambulatory care management·2020

Same author

MACRA and Accountable Care Organizations: Is It Working?

The Journal of ambulatory care management·2020

Same author

Reduction of Intensive Care Unit Length of Stay: The Case of Early Mobilization.

The health care manager·2020

Same author

The Growing Problem of Hepatitis C Virus Infection: The Case of West Virginia.

The health care manager·2019

Search research articles

Related Experiment Video

Updated: Jun 11, 2026

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Published on: December 22, 2023

Pharmaceutical counterfeiting and the RFID technology intervention.

Alberto Coustasse¹, Cody Arvidson, Phil Rutsohn

¹Lewis College of Business, Marshall University Graduate College, Charleston, West Virginia 25303, USA. coustassehen@marshall.edu

Journal of Hospital Marketing & Public Relations

|June 29, 2010

Summary

This summary is machine-generated.

Pharmaceutical counterfeiting poses global risks. Implementing Radio Frequency Identification Device (RFID) tracking in drug supply chains can significantly reduce the threat of counterfeit medications to public health and economic stability.

More Related Videos

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Isolation of Soil Microorganisms Using iChip Technology

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Enhanced Photoluminescence of Curcuma longa Extracts via Chitosan-Mediated Energy Transfer for Textile Authentication Applications

Published on: December 22, 2023

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Isolation of Soil Microorganisms Using iChip Technology

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Area of Science:

Pharmaceutical supply chain management
Public health and safety
Counterfeit drug detection

Background:

Pharmaceutical counterfeiting presents a significant global threat to both public health and economic stability.
Existing supply chain vulnerabilities allow for the widespread distribution of counterfeit drugs.
The scale and severity of the counterfeit drug problem necessitate innovative solutions.

Purpose of the Study:

To analyze the scope and severity of pharmaceutical counterfeiting.
To evaluate the potential of the Radio Frequency Identification Device (RFID) model in mitigating counterfeit drugs.
To assess the efficiency of RFID implementation within the pharmaceutical supply chain.

Main Methods:

Literature review and analysis of existing data on pharmaceutical counterfeiting.
Examination of the Radio Frequency Identification Device (RFID) model's applicability to pharmaceutical logistics.
Assessment of RFID's potential impact on drug traceability and security.

Main Results:

The implementation of the RFID model demonstrates significant potential to reduce the incidence and impact of counterfeit drugs.
Item-level tracking using RFID can enhance the security and integrity of the pharmaceutical supply chain.
The study confirms RFID's capability to alleviate the problem posed by counterfeit medications.

Conclusions:

Adoption of the RFID model is recommended for the pharmaceutical industry to combat counterfeiting.
Enhanced drug traceability through RFID can safeguard public health and international economic stability.
Proactive implementation strategies are crucial for the pharmaceutical sector to embrace RFID technology.